JPS5925325A - 癌治療剤 - Google Patents

癌治療剤

Info

Publication number
JPS5925325A
JPS5925325A JP13414582A JP13414582A JPS5925325A JP S5925325 A JPS5925325 A JP S5925325A JP 13414582 A JP13414582 A JP 13414582A JP 13414582 A JP13414582 A JP 13414582A JP S5925325 A JPS5925325 A JP S5925325A
Authority
JP
Japan
Prior art keywords
purine nucleotides
pentose
effect
antitumor
triphosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13414582A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0145450B2 (enrdf_load_stackoverflow
Inventor
Osamu Tamemasa
為政　脩
Masakatsu Tezuka
雅勝 手塚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP13414582A priority Critical patent/JPS5925325A/ja
Publication of JPS5925325A publication Critical patent/JPS5925325A/ja
Publication of JPH0145450B2 publication Critical patent/JPH0145450B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP13414582A 1982-07-30 1982-07-30 癌治療剤 Granted JPS5925325A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13414582A JPS5925325A (ja) 1982-07-30 1982-07-30 癌治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13414582A JPS5925325A (ja) 1982-07-30 1982-07-30 癌治療剤

Publications (2)

Publication Number Publication Date
JPS5925325A true JPS5925325A (ja) 1984-02-09
JPH0145450B2 JPH0145450B2 (enrdf_load_stackoverflow) 1989-10-03

Family

ID=15121515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13414582A Granted JPS5925325A (ja) 1982-07-30 1982-07-30 癌治療剤

Country Status (1)

Country Link
JP (1) JPS5925325A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003103323A (ja) * 2001-09-27 2003-04-08 Press Kogyo Co Ltd 積層金型

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS595116A (ja) * 1982-07-01 1984-01-12 Mitsui Toatsu Chem Inc 改良制癌剤
JPS5921618A (ja) * 1982-07-13 1984-02-03 エリ−ザ−・ラパポ−ト 抗癌剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS595116A (ja) * 1982-07-01 1984-01-12 Mitsui Toatsu Chem Inc 改良制癌剤
JPS5921618A (ja) * 1982-07-13 1984-02-03 エリ−ザ−・ラパポ−ト 抗癌剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003103323A (ja) * 2001-09-27 2003-04-08 Press Kogyo Co Ltd 積層金型

Also Published As

Publication number Publication date
JPH0145450B2 (enrdf_load_stackoverflow) 1989-10-03

Similar Documents

Publication Publication Date Title
DE3856557T2 (de) Acyldeoxyribonukleosid-Derivate und Verwendungen davon
Von Hoff et al. Phase I clinical investigation of 1, 4-dihydroxy-5, 8-bis {{{2-[(2-hydroxyethyl) amino] ethyl} amino}}-9, 10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione
CN100358512C (zh) 包含腺苷受体激动剂或拮抗剂的药物组合物
JP2003201240A (ja) アシル化ピリミジンヌクレオシドによる化学療法剤および抗ウイルス剤の毒性を減少させる方法
JPH02111724A (ja) アデニンヌクレオチドを有効成分とする血液および血漿中のアデノシン５’‐トリホスフェートレベルを増加させる薬剤
US4880918A (en) Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate
JPH06508846A (ja) アシル化ピリミジンヌクレオシドによる化学療法剤および抗ウイルス剤毒性の治療
EP0374096B1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
JP2011527678A (ja) 抗癌活性を有する２−デオキシ単糖の新規なアセテート
Calabresi et al. Clinical and pharmacological studies with 5-iodo-2′-deoxycytidine
Vecchi et al. Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerate
CN116726021A (zh) 一种drp1抑制剂和铁死亡诱导剂联合用药物及其抗肿瘤的用途
DE69333699T2 (de) Pyrimidinnukleotid-vorläufer zur behandlung entzündlicher hepatitis
Abele et al. Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
JPS637164B2 (enrdf_load_stackoverflow)
US4914105A (en) Anti-cancer compositions for delivering 5-fluorouracil
Alberto et al. A randomized comparison of doxifluridine and fluorouracil in colorectal carcinoma
KR100310121B1 (ko) 티아조푸린및리바비린을사용하는종양질환의치료방법
Taylor et al. Streptozotocin therapy for metastatic insulinoma
US4622325A (en) Anti-cancer composition for delivering 5-fluorouracil
Abele et al. Phase I Clinical Study With 5'-Deoxy-5-fluorouridine, a New Fluoropyrimidine Derivative1, 2
CN110664807B (zh) 一种具有协同抗黑色素瘤功效的药物组合物及其应用
US4719213A (en) Anti-cancer composition for delivering 5-fluorouracil
JPS5925325A (ja) 癌治療剤
DeWys et al. Synergistic antileukemic effect of theophylline and 1, 3-bis (2-chloroethyl)-1-nitrosourea